Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
3D & 4D Printing Methods for Pharmaceutical Manufacturing and Personalised Drug Delivery : Opportunities and Challenges / / edited by Dimitrios Lamprou
| 3D & 4D Printing Methods for Pharmaceutical Manufacturing and Personalised Drug Delivery : Opportunities and Challenges / / edited by Dimitrios Lamprou |
| Autore | Lamprou Dimitrios |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (329 pages) |
| Disciplina | 615.19 |
| Collana | AAPS Introductions in the Pharmaceutical Sciences |
| Soggetto topico |
Pharmaceutical chemistry
Drugs—Design Pharmacology Pharmaceutics Structure-Based Drug Design |
| ISBN | 3-031-34119-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 3D and 4D printing in digital healthcare -- 3D Printing for Novel Dosage Form Design -- 3D Printing and regulatory considerations -- Printability of Pharmaceutical Polymers: Issues & Solutions -- Quality by Design (QbD) approach for individualized products based on additive manufacturing,- Material Properties and Selections for Additive Manufacturing (AM) -- Preformulation of 3D printable pharmaceutical dosage forms -- Vat photopolymerization Methods for Drug Delivery Applications -- Extrusion-based 3D printing methods for oral solid dosage forms -- Binder Jetting 3D Printing in Pharmaceutical Manufacturing -- Powder bed fusion 3D printing in drug delivery -- Bioprinting in Personalised Medications -- Shape memory materials and 4D printing in pharmaceutics -- Characterisation methods of final printed products. |
| Record Nr. | UNINA-9910736994803321 |
Lamprou Dimitrios
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
ADME Processes in Pharmaceutical Sciences : Dosage, Design, and Pharmacotherapy / / edited by Alan Talevi, Pablo A. Quiroga
| ADME Processes in Pharmaceutical Sciences : Dosage, Design, and Pharmacotherapy / / edited by Alan Talevi, Pablo A. Quiroga |
| Autore | Talevi Alan |
| Edizione | [2nd ed. 2024.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (489 pages) |
| Disciplina | 615.19 |
| Altri autori (Persone) | QuirogaPablo A |
| Soggetto topico |
Pharmaceutical chemistry
Pharmacology Toxicology Pharmacy Drugs - Design Drug Design Drug Therapy Pharmacokinetics Drug-Related Side Effects and Adverse Reactions Technology, Pharmaceutical Pharmaceutics Structure-Based Drug Design |
| ISBN | 3-031-50419-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part 1: The basics of ADME processes -- Chapter 1-Introduction. Biopharmaceutics and Pharmacokinetics -- Chapter 2-Drug release -- Chapter 3-Drug Absorption -- Chapter 4-Drug Distribution -- Chapter 5-Drug Metabolism -- Chapter 6-Drug Excretion -- Chapter 7-Drug Delivery Routes -- Chapter 8-Compartmental Pharmacokinetic Models -- Chapter 9-Regulatory Requirements and Applications of Physiologically Based Pharmacokinetic Models -- Chapter 10-Drug Drug and Food Drug Interactions of Pharmacokinetic Nature -- Part 2: Specialized topics -- Chapter 11-Nanocarriers: Delivery Routes -- Chapter 12-Advanced Techniques for Quality Assessment of Nanocarriers -- Chapter 13-Nanomedicines Obtained by Nanoprinting -- Chapter 14-Absorption, Distribution, Metabolism and Excretion of Biopharmaceutical Drug Products -- Chapter 15-In silico and in vitro ADME predictions -- Chapter 16-Relationship Between Pharmacokinetics and Pharmacogenomics and Its Impact on Drug Choice and Dose Regimens -- Chapter 17-The Relationship Between Pharmacogenomics and Pharmacokinetics and Its Impact on Drug Choice and Dosing Regimens in Pediatrics -- Chapter 18-Bioavailability and Bioequivalence studies -- Chapter 19-Drug transporters – Physiological role and Their Impact on Pharmacotherapy -- Chapter 20-Blood Flow Distribution and Membrane Transporters As Determinant Factors Of Tissue Drug Concentration. |
| Record Nr. | UNINA-9910847085703321 |
|
Talevi Alan
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in Pharmacokinetics and Pharmacodynamics / / edited by Panos Macheras
| Advances in Pharmacokinetics and Pharmacodynamics / / edited by Panos Macheras |
| Autore | Macheras Panos |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (208 pages) |
| Disciplina | 615.7 |
| Collana | AAPS Introductions in the Pharmaceutical Sciences |
| Soggetto topico |
Drug delivery systems
Drugs—Design Pharmaceutical chemistry Metabolism Pharmacology Clinical biochemistry Drug Delivery Structure-Based Drug Design Pharmaceutics Medical Biochemistry |
| Soggetto non controllato |
Therapeutics
Medical |
| ISBN |
9783031295416
9783031295409 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Pharmacokinetics -- Chapter 1: Current status in PBPK modeling -- Chapter 2: Physiologically based biopharmaceutics modeling (PBBM) Application on Food Effect Assessment -- Chapter 3: Physiologically based finite time pharmacokinetic (PBFTPK) models: Inception and development -- Chapter 4: Physiologically based finite time pharmacokinetic (PBFTPK) models: Applications -- Pharmacodynamics -- Chapter 5: Pharmacokinetic – Pharmacodynamic Modelling and Simulation in Clinical Practice and Studies -- Chapter 6: On the Verge of Impossibility: Accounting for Variability Arising from Permutations of Comorbidities that Affect the Fate of Drugs in the Human Body -- Chapter 7: Impact of Clinical Pharmacology on the Modernization of Drug Development and Regulation. |
| Record Nr. | UNINA-9910728396903321 |
|
Macheras Panos
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomedical Translational Research : Drug Design and Discovery / / edited by R.C. Sobti, Naranjan S. Dhalla
| Biomedical Translational Research : Drug Design and Discovery / / edited by R.C. Sobti, Naranjan S. Dhalla |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (597 pages) |
| Disciplina | 610.28 |
| Soggetto topico |
Medicine - Research
Biology - Research Drugs - Design Pharmaceutical chemistry Genomics Bioinformatics Biomedical Research Structure-Based Drug Design Pharmaceutics Disseny de medicaments Enginyeria biomèdica |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-16-9232-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Emerging Technologies : Gateway to Understand Molecular Insight of Diseases, Newer Drugs, Their Design and Targeting -- Chapter 2. Polypharmacology: New Paradigms in Drug Development -- Chapter 3. Drug Repurposing in Biomedical Research : Benefits and Challenges -- Chapter 4. Computational Methods for Drug Repurposing -- Chapter 5. Genomic Approaches for Drug Repositioning -- Chapter 6. Organ-On-A- Chip: Novel in-Vitro Model For Drug Discovery -- Chapter 7. Precision Radiomolecular Oncology: Challenging the Classical Statistical Evidence Based Medicine -- Chapter 8. Drug Repositioning of the Phenylpiperazine Derivative Naftopidil in Prostate Cancer Treatment -- Chapter 9. Biomarker Based Drug Discovery and Reverse Translational Approach -- Chapter 10. Nanotechnology in Dentistry -- Chapter 11. Nanoparticles a Potential Breakthrough in Counteracting Multidrug-Resistant Bacterial Infections: A Holistic View on Underlying Mechanisms and Antibacterial Properties -- Chapter 12. Emerging Role of Cannabinoid System Modulators in Treatment of Cancer -- Chapter 13. Nanodrugs : A Futuristic Approach for Treating Nephrolithiasis -- Chapter 14. Lipo Dermaceuticals : Technological Transformation -- Chapter 15. The Importance of Drug Dose Adjustment in Elderly Patients with Special Considerations for Patients on Diverse Co-Medications and Antidepressants -- Chapter 16. Role of Microfluidics and Nano Fluidics in Managing CAD -- Chapter 17. Targeted Gene Delivery Through Magnetofection: The New Face of Medicine -- Chapter 18. Qbd-Steered Systematic Development of Drug Delivery Nanoconstructs : Vital Precepts, Retrospect and Prospects -- Chapter 19. Nanoemulsions: A Potential Advanced Nanocarrier Platform for Herbal Drug Delivery -- Chapter 20. Sirna Encapsulated Nanoparticles for Targeting Dorsal Root Ganglion (Drg) in Diabetic Neuropathic Pain -- Chapter 21. EGFR Targeted Quinazoline Clubbed Heterocycles as Anti-Cancer Agents. Chapter 22. Therapeutic Human Monoclonal Antibodies -- Chapter 23. Hydroxyapatites and Their Biomedical Applications -- Chapter 24. Recent Progress in Applications of Magnetic Nanoparticles in Medicine: A Review -- Chapter 25. Chimeric Antigen Receptor T-Cell Therapy: A Cutting Edge Therapy for Multiple Myeloma -- Chapter 26. Nanoparticles-Associated Lipopeptides: A New Class of Antimicrobials -- Chapter 27. Antimicrobial Applications of Engineered Metal-Based Nanomaterials -- Chapter 28. Strengthening Immunity-Ayurveda & Medicinal Plants -- Chapter 29. The Pathophysiology of Liver Disorders and Pharmacotherapy Options with Special Reference to Traditional Herbal Medicines: A Comprehensive Review -- Chapter 30. Polymeric Vehicles for Controlled Delivery of Ayurvedic Drugs for Wound Management. |
| Record Nr. | UNINA-9910585974703321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
CADD and Informatics in Drug Discovery / / edited by Mithun Rudrapal, Johra Khan
| CADD and Informatics in Drug Discovery / / edited by Mithun Rudrapal, Johra Khan |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (370 pages) |
| Disciplina | 615.1900285 |
| Collana | Interdisciplinary Biotechnological Advances |
| Soggetto topico |
Biology
Bioinformatics Medicine—Research Biology—Research Pharmacy Drugs—Design Biotechnology Biological Sciences Biomedical Research Structure-Based Drug Design |
| ISBN |
9789819913169
9789819913152 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1: Fundamentals of Computational Drug Design Approaches (CADD) -- Chapter 2: Molecular and Computational Modeling in Drug Design -- Chapter 3: Bioinformatics/Chemo-informatics Tools and Database in Drug Discovery -- Chapter 4: Computational Screening of Phytochemicals/Natural Products in Drug Discovery -- Chapter 5: Virtual Screening in Lead Discovery and Optimization -- Chapter 6: Target-based Screening (SBDD) in Lead Discovery -- Chapter 7: Pharmacophore-based and Similarity Search (LBDD) Screening in Lead Discovery -- Chapter 8: Receptor-based De Novo and Fragment-based Drug Design -- Chapter 9: Artificial Intelligence and Machine Learning in Drug Discovery -- Chapter 10: Network Pharmacology and System Biology Approaches -- Chapter 11: In Silico Pharmacology and Drug Repurposing Approaches -- Chapter 12: Advances in Bioinformatics and Computational Approaches in Drug Discovery -- Chapter 13: Challenges in Bioinformatics and Computational Approaches in Drug Discovery. |
| Record Nr. | UNINA-9910725088603321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Challenges and Solutions Against Visceral Leishmaniasis [[electronic resource] /] / edited by Angamuthu Selvapandiyan, Ruchi Singh, Niti Puri, Nirmal K. Ganguly
| Challenges and Solutions Against Visceral Leishmaniasis [[electronic resource] /] / edited by Angamuthu Selvapandiyan, Ruchi Singh, Niti Puri, Nirmal K. Ganguly |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (XXI, 449 p. 36 illus., 34 illus. in color.) |
| Disciplina | 571.999 |
| Soggetto topico |
Parasitology
Drugs - Design Pharmaceutical chemistry Epidemiology Structure-Based Drug Design Pharmaceutics |
| ISBN | 981-9969-99-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Module 1_Epidemiology and Surveillances -- Module 2_Omics and Advancement in Diagnosis -- Module 3_Genetics -- Module 4_New Drug Discovery Opportunity -- Module 5_Immunity and Vaccine Development. |
| Record Nr. | UNINA-9910806194803321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Current Trends in Computational Modeling for Drug Discovery / / edited by Supratik Kar, Jerzy Leszczynski
| Current Trends in Computational Modeling for Drug Discovery / / edited by Supratik Kar, Jerzy Leszczynski |
| Autore | Kar Supratik |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (311 pages) |
| Disciplina |
541.2
615.19 |
| Altri autori (Persone) | LeszczynskiJerzy |
| Collana | Challenges and Advances in Computational Chemistry and Physics |
| Soggetto topico |
Drugs—Design
Molecules—Models Chemistry—Data processing Medicinal chemistry Pharmacology Structure-Based Drug Design Molecular Modelling Computational Chemistry Medicinal Chemistry |
| ISBN | 3-031-33871-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | SBDD and its challenges -- In silico discovery of class IIb HDAC inhibitors: The state of art -- Role of computational modelling in drug discovery for Alzheimer’s disease -- Computational Modeling in the Development of Antiviral Agents -- Targeted computational approaches to identify potential inhibitors for Nipah virus -- Role of Computational Modelling in Drug Discovery for HIV -- Recent insight of the emerging severe fever with thrombocytopenia syndrome virus: drug discovery, therapeutic options, and limitations -- Computational toxicological aspects in drug design and discovery, screening adverse effects -- Read-Across and RASAR tools from the DTC Laboratory -- Databases for Drug Discovery and Development. |
| Record Nr. | UNINA-9910734828903321 |
|
Kar Supratik
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Essential Pharmaceutics [[electronic resource] /] / by Ashlee D. Brunaugh, Daniel Moraga-Espinoza, Tania F. Bahamondez-Canas, Hugh D. C. Smyth, Robert O. Williams
| Essential Pharmaceutics [[electronic resource] /] / by Ashlee D. Brunaugh, Daniel Moraga-Espinoza, Tania F. Bahamondez-Canas, Hugh D. C. Smyth, Robert O. Williams |
| Autore | Brunaugh Ashlee D |
| Edizione | [2nd ed. 2024.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (243 pages) |
| Disciplina | 615.19 |
| Altri autori (Persone) |
Moraga-EspinozaDaniel
Bahamondez-CanasTania F SmythHugh D. C WilliamsRobert O |
| Collana | AAPS Introductions in the Pharmaceutical Sciences |
| Soggetto topico |
Pharmaceutical chemistry
Drug delivery systems Biomaterials Drugs - Design Pharmaceutics Drug Delivery Structure-Based Drug Design |
| ISBN | 3-031-52520-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1: Essential Pharmaceutics in the Flipped-Classroom. - Chapter 2: Overview of Biopharmaceutics and Regulatory Concepts Relevant to Drug Product Design -- Chapter 3: Preformulation in Drug Product Design -- Chapter 4: Capsule and Tablet Dosage Forms -- Chapter 5: Modified Release Solid Oral Dosage Forms -- Chapter 6: Solution-Based Dosage Forms and Sterile Products -- Chapter 7: Disperse Systems – Suspensions -- Chapter 8: Disperse Systems – Emulsions -- Chapter 9: Ophthalmic and Otic Drug Delivery -- Chapter 10: Topical and Transdermal Drug Delivery -- Chapter 11: Oral Transmucosal Delivery -- Chapter 12: Rectal and Vaginal Drug Delivery -- Chapter 13: Pulmonary Drug Delivery -- Chapter 14: Nasal Drug Delivery -- Chapter 15: Drug Product Design and Delivery of Biologics. |
| Record Nr. | UNINA-9910838284503321 |
|
Brunaugh Ashlee D
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Medicinal Chemistry of Glucocorticoid Receptor Modulators / / by Adrian Hobson
| The Medicinal Chemistry of Glucocorticoid Receptor Modulators / / by Adrian Hobson |
| Autore | Hobson Adrian |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (IX, 142 p. 172 illus.) |
| Disciplina |
612.405
615.77 |
| Collana | SpringerBriefs in Molecular Science |
| Soggetto topico |
Medicinal chemistry
Pharmaceutical chemistry Drugs - Design Chemistry - Data processing Chemistry - History Medicinal Chemistry Pharmaceutics Structure-Based Drug Design Computational Chemistry History of Chemistry |
| ISBN | 3-031-28732-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- cortisol-based glucocorticoids -- metabolically inactivated glucocorticoids -- prodrugs -- selective glucocorticoid receptor modulators -- polymers and particles -- QSAR and Modelling -- Antibody Drug Conjugates -- Conclusion. |
| Record Nr. | UNINA-9910686469303321 |
|
Hobson Adrian
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Natural Product Based Drug Discovery Against Human Parasites : Opportunities and Challenges / / edited by Archana Singh, Brijesh Rathi, Anita K. Verma, Indrakant K. Singh
| Natural Product Based Drug Discovery Against Human Parasites : Opportunities and Challenges / / edited by Archana Singh, Brijesh Rathi, Anita K. Verma, Indrakant K. Singh |
| Autore | Singh Archana |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (602 pages) |
| Disciplina | 616.96 |
| Altri autori (Persone) |
RathiBrijesh
VermaAnita K SinghIndrakant K |
| Soggetto topico |
Parasitology
Medical microbiology Pharmacology Drugs - Design Medical Microbiology Structure-Based Drug Design |
| ISBN | 981-19-9605-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Recent advances on the discovery of plants derived bioactive scaffolds/extracts against parasitic diseases -- Chapter 2. Applications of Computational Methods in Natural Products based Drug Discovery -- Chapter 3. Natural Product-Based Drug Designing for treatment of Human parasitic diseases -- Chapter 4. Secondary Metabolites of Plant Origin in Parasitic manifestations -- Chapter 5. Exploring marine biodiversity as alternative resources for treatment of Human Parasitic Diseases -- Chapter 6. Marine Bioprospecting for the Treatment of Human Parasitic Diseases -- Chapter 7. Microorganisms-Derived Biochemicals: Potential Drugs for Human Parasitic Diseases -- Chapter 8. Plant-Based Vaccines against Human Parasitic Diseases -- Chapter 9. Nanotechnology: its usages in drug delivery for the treatment of Human Parasitic Diseases -- Chapter 10. Therapeutic Potential Of Benzopyrones Against Antiparasitic Diseases -- Chapter 11. Antimicrobial peptides (AMPs): current state and future prospects for the treatment of human parasitic diseases -- Chapter 12. Pathway To Register Natural Product-Derived Therapeutics -- Chapter 13. Recent Advances in the Treatment of Parasitic Diseases: Current Status and Future -- Chapter 14. Strategies and challenges for developing plant-based therapeutics against Protozoans -- Chapter 15. Recent approaches to combat toxoplasma gondii with plant-derived alternatives -- Chapter 16. Target-based rational improvement strategies and pitfalls in Leishmania drug discovery -- Chapter 17. Versatile Structurally Diverse Natural Products and Their Semisynthetic Analogs as Potential Anti-leishmanial Drugs -- Chapter 18. Promising compounds of plant origin and their synthetic analogs against Trypanosomes -- Chapter 19. Pathogenesis and Immune Response inT. cruzi infection: Quest for Natural compound-based drugs -- Chapter 20. Limitations of current drugs and prospects of plant-based compounds and their constructed analogues as therapeutics for treatment of malaria -- Chapter 21. An Analytical Approach to Progression in Malaria Therapeutics -- Chapter 22. Malaria Drug Discovery: How to tackle the problem of Drug Resistance -- Chapter 23. Approaches to drug discovery against Ascariasis: Opportunity and challenges in plant-based products -- Chapter 24. The Potential of Plant Secondary Metabolites as Drugs or Leads Against Helminths -- Chapter 25. Drug Resistance in Helminth parasites: Role of plant based natural therapeutics -- Chapter 26. Schistosomiasis: current and future strategies to develop novel therapeutics. |
| Record Nr. | UNINA-9910766882803321 |
|
Singh Archana
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Structure-Based Drug Design
(14)
- Pharmaceutical chemistry (10)
- Pharmaceutics (10)
- Drugs - Design (9)
- Pharmacology (9)